152 related articles for article (PubMed ID: 23639362)
41. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
42. Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson's disease.
Rekha KR; Selvakumar GP
Chem Biol Interact; 2014 Jun; 217():57-66. PubMed ID: 24768735
[TBL] [Abstract][Full Text] [Related]
43. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
Jiang H; Li LJ; Wang J; Xie JX
Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
45. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
Zhao Q; Gao J; Li W; Cai D
Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
[TBL] [Abstract][Full Text] [Related]
46. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
47. α-lipoic acid protects dopaminergic neurons against MPP+-induced apoptosis by attenuating reactive oxygen species formation.
Li DW; Li GR; Lu Y; Liu ZQ; Chang M; Yao M; Cheng W; Hu LS
Int J Mol Med; 2013 Jul; 32(1):108-14. PubMed ID: 23615851
[TBL] [Abstract][Full Text] [Related]
48. Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells.
Lu XL; Lin YH; Wu Q; Su FJ; Ye CH; Shi L; He BX; Huang FW; Pei Z; Yao XL
BMC Complement Altern Med; 2015 Apr; 15():137. PubMed ID: 25925762
[TBL] [Abstract][Full Text] [Related]
49. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q
Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717
[TBL] [Abstract][Full Text] [Related]
50. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
Zhang HN; An CN; Zhang HN; Pu XP
Neurosci Lett; 2010 Apr; 474(2):99-103. PubMed ID: 20227465
[TBL] [Abstract][Full Text] [Related]
51. Cold water stress attenuates dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Xia M; Bian M; Yu Q; Liu J; Huang Y; Jin X; Lu S; Yu M; Huang F
Acta Biochim Biophys Sin (Shanghai); 2011 Jun; 43(6):448-54. PubMed ID: 21558280
[TBL] [Abstract][Full Text] [Related]
52. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Xiao YL; Fu JM; Dong Z; Yang JQ; Zeng FX; Zhu LX; He BC
Acta Pharmacol Sin; 2004 Mar; 25(3):301-5. PubMed ID: 15000882
[TBL] [Abstract][Full Text] [Related]
53. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.
Youdim MB; Arraf Z
Neuropharmacology; 2004 Jun; 46(8):1130-40. PubMed ID: 15111020
[TBL] [Abstract][Full Text] [Related]
54. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
Mitsumoto Y; Watanabe A; Mori A; Koga N
Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
[TBL] [Abstract][Full Text] [Related]
56. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
[TBL] [Abstract][Full Text] [Related]
57. Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration.
Kenchappa RS; Diwakar L; Annepu J; Ravindranath V
FASEB J; 2004 Jul; 18(10):1102-4. PubMed ID: 15132975
[TBL] [Abstract][Full Text] [Related]
58. G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP
Yuan LJ; Wang XW; Wang HT; Zhang M; Sun JW; Chen WF
J Steroid Biochem Mol Biol; 2019 Sep; 192():105384. PubMed ID: 31175966
[TBL] [Abstract][Full Text] [Related]
59. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
60. Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice.
Ruan H; Yang Y; Zhu X; Wang X; Chen R
Neurosci Lett; 2009 Jan; 450(2):152-7. PubMed ID: 19070648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
